Skip to content

US · AHR · REIT - HEALTHCARE FACILITIES

American Healthcare REIT, Inc. (AHR) intrinsic value and stock valuation

$57.54as of 2026-11-21 · Mkt cap 11.47B

Data updated · price as of 2026-11-21

Strongly overvaluedIC value is more than 50% below the price. The exact IC value, upside and the fair-value band are available with Pro.
P/E
Pro
P/B
Pro
P/S
Pro

Price history

Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.

American Healthcare REIT, Inc. DCF and intrinsic value

InvestorsCraft values AHR with the Chepakovich two-stage DCF model — currently rated strongly overvalued. How the model works · Run your own DCF prefilled from AHR’s statements →

American Healthcare REIT, Inc. Graham Number

Graham Number: $13.84d — the price is above the Graham Number. Formula √(22.5 × EPS × BVPS) using the latest diluted EPS and book value per share. Guide · Calculator →

Real Estate · REIT - Healthcare Facilities Irvine, CA 92612-7106 americanhealthcarereit.com

How the business is doing

Fiscal 2016–2025, USD

Revenue
$2.26B+13.8% 5y CAGRd
20162025
Net income
$69.8M+100.4% 5y CAGRd
20162025
Free cash flow
$165.9M+12.8% 5y CAGRd
20162025
Total equity
$3.36B+25.6% 5y CAGRd
20162025

Is it expensive?

Each multiple against its own 15-year range, or against peers where no history is available

P/E
Pro
with Pro
P/B
Pro
with Pro
P/S
Pro
with Pro
EV/EBITDA
Pro
with Pro
P/EG
Pro
with Pro
P/TBV
Pro
with Pro

Peers

Same-industry companies, ranked by market cap

Peer comparison

The peer comparison table is shown only to users with a Pro subscription.

Financials

Statements by fiscal year

Fiscal 2016–2025, USD
20252024202320222021
Revenue$2.26B$2.07B$1.86B$1.62B$1.26B
Operating income$167.8M$136.8M$76.7M$90.6M$138.8M
Net income$69.8M-$-37.81M-$-71.47M-$-81.3M-$-47.79M
EPSd$418.4K-$-289.42K-$-1.08M-$-1.23M-$-721.79K
Operating cash flow$294.4M$176.1M$98.5M$147.8M$17.9M
Capital expenditure-$-128.56M-$-91.94M-$-99.79M-$-71.52M-$-79.69M
Free cash flow$165.9M$84.2M-$-1.26M$76.3M-$-61.78M
Total assets$5.43B$4.49B$4.58B$4.79B$4.58B
Total debt$1.69B$1.87B$3.02B$2.83B$2.5B
Net debt$1.57B$1.79B$2.98B$2.77B$2.42B
Total equity$3.36B$2.3B$1.46B$1.65B$1.83B
Cash and short-term investments$114.8M$76.7M$43.5M$65.1M$81.6M
Income statement
20252024202320222021
Revenue$2.26B$2.07B$1.86B$1.62B$1.26B
Cost of revenue$2.22B$1.65B$1.5B$1.28B$1.08B
Gross profit$39.7M$416.8M$356.8M$336M$182M
Research and development expenses$0.00$0.00$0.00$0.00$0.00
Selling, general and administrative expenses$0.00$100.8M$105M$103.1M$43.2M
Other expenses-$-128.14M$179.2M$175.1M$142.3M$0.00
Operating expenses-$-128.14M$280M$280.1M$245.4M$43.2M
Cost and expenses$2.09B$1.93B$1.78B$1.53B$1.13B
Interest income$0.00$0.00$0.00$0.00$0.00
Interest expense$85.8M$127.7M$163.2M$106M$80.9M
Depreciation and amortization$187.6M$221.6M$237.3M$200.6M$153.8M
Ebitda$322M$315.5M$324.3M$233.8M$159.4M
Operating income$167.8M$136.8M$76.7M$90.6M$138.8M
Total other income/expenses, net-$-119.19M-$-170.67M-$-152.94M-$-163.39M-$-191.12M
Income before tax$48.7M-$-33.89M-$-76.22M-$-72.8M-$-52.31M
Income tax expense-$-22.17M$1.71M$660K$590K$960K
Net income$69.8M-$-37.81M-$-71.47M-$-81.3M-$-47.79M
Weighted average shares outstanding$166.1M$130.6M$66.1M$66.2M$66.2M
Weighted average diluted shares outstanding$166.9M$130.6M$66.1M$66.2M$66.2M
Balance sheet
20252024202320222021
Cash and short-term investments$114.8M$76.7M$43.5M$65.1M$81.6M
Net receivables$204.3M$211.1M$185.4M$184.4M$163.8M
Inventory$0.00$19.5M$19.5M$19.8M$18.9M
Total current assets$319.2M$354.9M$297.1M$341.9M$330.7M
Property, plant and equipment, net$271M$164M$227.9M$3.86B$3.67B
Goodwill and intangible assets$488.2M$396.4M$415.4M$467.9M$458.8M
Long-term investments$4.28B$105.2M$107.6M$92.6M$94.9M
Total non-current assets$759.2M$4.13B$4.28B$4.44B$4.25B
Total assets$5.43B$4.49B$4.58B$4.79B$4.58B
Accounts payable$317.7M$258.3M$242.9M$83.7M$64.4M
Short-term debt$549.8M$688.5M$1.45B$316.7M$921.9M
Deferred revenue$0.00$0.00$0.00$0.00$0.00
Total current liabilities$867.5M$946.9M$1.47B$560.6M$1.11B
Long-term debt$1.14B$1.18B$1.57B$2.52B$1.58B
Deferred revenue, non-current$0.00$0.00$0.00$0.00$0.00
Total non-current liabilities$1.2B$1.24B$1.65B$2.58B$1.64B
Capital lease obligations$135.6M$165.2M$451M$273.1M$145.5M
Total liabilities$2.07B$2.18B$3.12B$3.14B$2.75B
Common stock$1.85M$1.56M$660K$660K$660K
Retained earnings-$-1.56B-$-1.46B-$-1.28B-$-1.14B-$-951.3M
Accumulated other comprehensive income (loss)-$-2.1M-$-2.51M-$-2.42M-$-2.69M-$-1.97M
Total equity$3.36B$2.3B$1.46B$1.65B$1.83B
Total investments$4.28B$105.2M$107.6M$92.6M$94.9M
Total debt$1.69B$1.87B$3.02B$2.83B$2.5B
Net debt$1.57B$1.79B$2.98B$2.77B$2.42B
Cash flow statement
20252024202320222021
Net income$70.8M-$-35.6M-$-76.89M-$-73.38M-$-53.27M
Depreciation and amortization$225.2M$221.6M$237.3M$200.6M$157.4M
Stock-based compensation$14.6M$9.87M$5.47M$3.91M$9.66M
Change in working capital-$-30.32M-$-68.68M-$-55.79M-$-37.8M-$-93.47M
Accounts receivable-$-13.05M-$-23.75M-$-34.72M-$-4.46M$3.69M
Inventory$0.00$0.00$0.00$0.00$0.00
Accounts payable$29M-$-650K$15.4M$13.9M-$-39.71M
Net cash provided by operating activities$294.4M$176.1M$98.5M$147.8M$17.9M
Investments in property, plant and equipment-$-128.56M-$-91.94M-$-99.79M-$-71.52M-$-79.69M
Acquisitions, net-$-118.84M-$-230K-$-12.93M-$-18.57M-$-650K
Net cash used for investing activities-$-1.08B-$-8.73M$9.4M-$-118.58M-$-138.65M
Common stock issued$1.15B$1.36B$0.00$0.00$0.00
Common stock repurchased$240K-$-10K-$-470K-$-20.7M-$-380K
Dividends paid-$-163.52M-$-120.89M-$-76.28M-$-51.12M-$-22.79M
Net cash used for financing activities$817.5M-$-134.74M-$-129.06M-$-42.92M$94.1M
Net change in cash$28.5M$32.5M-$-21.12M-$-13.58M-$-26.7M
Cash at end of period$151.8M$123.3M$90.8M$111.9M$125.5M
Operating cash flow$294.4M$176.1M$98.5M$147.8M$17.9M
Capital expenditure-$-128.56M-$-91.94M-$-99.79M-$-71.52M-$-79.69M
Free cash flow$165.9M$84.2M-$-1.26M$76.3M-$-61.78M
USD millions

Line items

    USD millions

    Line items

      USD millions

      Line items

        About American Healthcare REIT, Inc.

        American Healthcare REIT (AHR) was forged through a significant strategic consolidation, combining Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, along with integrating the business and operations of American Healthcare Investors. This comprehensive merger has established AHR as a leading global real estate investment trust focused on healthcare properties, boasting an impressive portfolio with a gross investment value of approximately $4.2 billion. A core strength of the company lies in its fully integrated management platform, staffed by over one hundred highly experienced and proficient professionals. Many members of this team have a long history of collaboration, dating back to 2006, and have successfully invested in and overseen healthcare real estate assets across diverse market cycles. Their collective expertise, extensive industry network, and deep, firsthand understanding of each property within the international portfolio – which they have meticulously built and managed since its first acquisition in 2014 – are unparalleled. This powerful combination of a robust management team and a high-quality asset base strategically positions American Healthcare REIT to capitalize on compelling growth opportunities, driven by significant demographic trends. Its expansive portfolio encompasses 19 million square feet across 312 distinct properties, including medical office buildings, senior housing communities, skilled nursing facilities, and integrated senior health campuses. This diverse collection is strategically distributed across 36 U.S. states and the United Kingdom. The aforementioned tri-party transaction represented a pivotal step in ideally preparing American Healthcare REIT for a future public listing or Initial Public Offering (IPO) on a national stock exchange when market conditions are most favorable. By eventually listing its shares, the company anticipates gaining enhanced access to attractive capital sources, which will be crucial for fueling future expansion, diversifying its investor base, and providing greater liquidity for its existing stockholders. American Healthcare REIT, Inc. operates as a subsidiary of Griffin Capital Company, LLC.

        CEO
        Jeffrey T. Hanson
        Employees
        121
        Beta
        0.78

        Explore

        Frequently asked questions

        What is the intrinsic value of American Healthcare REIT, Inc. (AHR)?

        American Healthcare REIT, Inc. (AHR) is currently strongly overvalued based on the InvestorsCraft IC model — IC value is more than 50% below the price. The exact intrinsic value is available to Pro subscribers. How the IC value is calculated.

        Is AHR undervalued?

        AHR trades at a price of $57.54 (Nov 21, 2026): strongly overvalued — IC value is more than 50% below the price.

        How is the intrinsic value calculated?

        InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.

        How often is this page updated?

        Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.

        Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.